BW Gestao de Investimentos Ltda. raised its stake in shares of Clarivate Plc (NYSE:CLVT - Free Report) by 215.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,273,175 shares of the company's stock after acquiring an additional 2,236,942 shares during the period. Clarivate makes up 0.5% of BW Gestao de Investimentos Ltda.'s investment portfolio, making the stock its 17th biggest holding. BW Gestao de Investimentos Ltda. owned 0.46% of Clarivate worth $16,628,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds also recently added to or reduced their stakes in CLVT. GAMMA Investing LLC grew its position in Clarivate by 161.4% in the 4th quarter. GAMMA Investing LLC now owns 5,256 shares of the company's stock valued at $27,000 after buying an additional 3,245 shares during the last quarter. RPO LLC purchased a new stake in shares of Clarivate in the fourth quarter valued at about $55,000. Schonfeld Strategic Advisors LLC acquired a new position in shares of Clarivate during the fourth quarter worth about $56,000. Kathmere Capital Management LLC purchased a new position in shares of Clarivate during the 4th quarter worth approximately $58,000. Finally, Truist Financial Corp lifted its holdings in shares of Clarivate by 27.3% in the 4th quarter. Truist Financial Corp now owns 14,000 shares of the company's stock valued at $71,000 after buying an additional 3,000 shares during the period. 85.72% of the stock is owned by institutional investors and hedge funds.
Clarivate Price Performance
Shares of CLVT stock traded down $0.02 during midday trading on Friday, reaching $4.30. 2,449,507 shares of the company traded hands, compared to its average volume of 5,201,168. The firm's 50 day simple moving average is $3.86 and its two-hundred day simple moving average is $4.78. The firm has a market cap of $2.94 billion, a PE ratio of -4.48 and a beta of 1.49. The company has a debt-to-equity ratio of 0.88, a current ratio of 0.87 and a quick ratio of 0.88. Clarivate Plc has a 1-year low of $3.04 and a 1-year high of $7.15.
Clarivate (NYSE:CLVT - Get Free Report) last posted its earnings results on Tuesday, April 29th. The company reported $0.14 EPS for the quarter, topping analysts' consensus estimates of $0.12 by $0.02. Clarivate had a positive return on equity of 9.10% and a negative net margin of 24.90%. The company had revenue of $593.70 million for the quarter, compared to the consensus estimate of $574.03 million. During the same period in the previous year, the business earned $0.14 earnings per share. Clarivate's quarterly revenue was down 4.4% compared to the same quarter last year. On average, equities research analysts expect that Clarivate Plc will post 0.63 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Separately, Royal Bank of Canada reiterated a "sector perform" rating and issued a $6.00 price objective on shares of Clarivate in a research report on Thursday, February 20th.
View Our Latest Research Report on CLVT
Clarivate Profile
(
Free Report)
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
See Also

Before you consider Clarivate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.
While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.